The casein kinase 2 inhibitor, CX-4945, as an anti-cancer drug in treatment of human hematological malignancies

Journal

• Frontiers in Pharmacology

  Frontiers in Pharmacology 6 70-, 2015-03-31

  Frontiers Media SA